Evidence-based operational and strategic behavior of
|
|
- Georgiana Tucker
- 6 years ago
- Views:
Transcription
1 Closing the Loop: Optimizing Physicians Operational and Strategic Behavior Paul T. Sergeant, MD, PhD, and Eugene H. Blackstone, MD Katholieke Universiteit Leuven, Leuven, Belgium, and The Cleveland Clinic Foundation, Cleveland, Ohio Clinical databases are essential elements in optimizing medical care. They are no finality by themselves, but essential elements in the generation of knowledge. Optimal medical care starts with optimal care based on existing knowledge. This care continues with the registration of the variability in morbidity, comorbidity, and therapy, but also the registration of the early and late outcome. This should then allow the generation of structured inferences based on this registration and the closure of the loop, by treating patients according to this newly created evidence. (Ann Thorac Surg 1999;68:362 6) 1999 by The Society of Thoracic Surgeons Presented at the Thirty-fourth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 26 28, Address reprint requests to Dr Sergeant, Department of Cardiac Surgery, Gasthuisberg University Hospital, Herestraat, 3000 Leuven, Belgium; Evidence-based operational and strategic behavior of clinicians should be based on knowledge generated by following patients during their treatment, but also beyond their hospital stay, and preferably for as long as possible, until the end of the patient s life. This knowledge should include the interaction of the patient s morbidity and comorbidity, the specificity of the disease and the intervention, and environmental factors. The purpose of this manuscript and presentation is to follow the path of these data, from the generation of information up to the generation of knowledge useful for an individual patient or a population. The generation of information has to follow methodological rules and constraints. The first of these is a methodology for overcoming the absence in the late 20th century of complete, longitudinal, patient records of all health care information. Important morbid events may be forgotten if a patient is contacted at infrequent intervals, or if only vital status information is available from national databases. Therefore, when the K.U. Leuven Coronary Surgery Database was established, a doublecore data system for patient follow-up was incorporated. First, there was an unformalized update by a regular stream of follow-up reports by referring cardiologists. Because most of them trained at our University Hospital, we have encouraged them to send reports after each regular visit. Visits to the cardiologists are financially neutral for the patient in the Belgian Health Care system. In addition to this real-time update, two (1987 and 1993) cross-sectional follow-up studies were performed of known surviving patients using the very strict common closing date methodology. This methodology fulfills the theoretical assumptions of actuarial methods. Others have implemented similar multitiered follow-up systems, but using an anniversary follow-up scheme for obtaining systematic information. This scheme also fulfills the theoretical assumptions of actuarial methods. This cross-sectional follow-up is managed and monitored by a self-developed information management system, directly integrated in the K.U. Leuven Coronary Surgery Database. Figure 1 describes the different loops of step 1, taking place after defining the common closing date. Figure 2 describes some of the different loops of steps 2 and 3, when the patient is identified as deceased or if events have taken place in follow-up. The loops of step 2 stop only when the senior researcher (a cardiac surgeon) has spoken with a person who was present at the time and place of death of the patient. This is very important for a correct classification of the mode of death, just as important as a complete insight into the events and status of the patient in the weeks and months before death. Death is always sudden and unexpected for the close relatives of a patient. A more profound analysis frequently corrects this information. Systematic follow-up is time consuming and expensive. For us, the second cross-sectional follow-up of 9600 patients took more than 24 months from the direct mail date of the first letter to the patient. These first letters were sent in the week after the common closing date. At that time, all preoperative, operative, and hospital data had been completed. The information management system performed well, and complete follow-up was obtained of 99.9% of the patients. Generally, systems optimized for data gathering, information management, and data updating and verification are not optimized for sophisticated statistical data analysis. Generally, a snapshot is needed of the data relevant to the analysis. Importantly, all data corrections discovered during analysis are fed back to the primary database. In our case, data were transferred from the database computing system into the data analysis computing system of the University of Alabama at Birmingham. Even in an ideal future setting of existing computerized longitudinal patient medical records, a data 1999 by The Society of Thoracic Surgeons /99/$20.00 Published by Elsevier Science Inc PII S (99)00627-X
2 Ann Thorac Surg SERGEANT AND BLACKSTONE 1999;68:362 6 CLOSING THE LOOP 363 Fig 1. Step 1 in the generation of information: obtaining the status of the patient at the common closing date. analysis phase would require extraction of values for variables across multiple patient records at some specific point in time. Fig 2. Step 2 (a deceased patient) and step 3 (an event, symptom, or procedure) in the generation of information, once the status of the patient has been identified. Data analysis must also be approached purposefully, methodically, and with clear questions in mind. The analysis begins with assessing the quality, completeness, and relevance of the study endpoints (outcomes) and variables. These are then organized into medically meaningful clusters. Formalization of this step has become popularly known as an important aspect of data mining. This is followed by investigation of the relation of each variable in isolation to outcomes. For ordinal (ordered categorical information) and continuous variables, transformations of scale must be sought so as to best fulfill the assumptions of the underlying statistical models. Table 1 lists some of the steps in data exploration preceding and finally including the generation of patientspecific predictions and nomograms usable for optimizing therapeutic decision making. This process is labor intensive and requires a close and permanent collaboration between the data analyst and the clinician. Only then are the data ready for initial multivariable analysis. The creation of interaction variables and the grouping of categorical variables should be based on extensive clinical experience and previous literature review. The K.U. Leuven Coronary Surgery database started off with many hundreds of variables, describing the patient, procedural, and institutional variability. The optimization process of the variables through transformation and grouping increases this number even further. Unexplored domains and relations become visible and disappear during the mandatory data exploration, and the foundations of the multivariable analysis are laid. The generation of knowledge starts when the parametric multivariable model has been created [1]. One reason for use of parametric modeling is that the model can be explored graphically (which we have termed nomo-
3 364 SERGEANT AND BLACKSTONE Ann Thorac Surg CLOSING THE LOOP 1999;68:362 6 Table 1. The Different Steps in Data Exploration and Analysis Leading to the Generation of Patient-Specific Predictions and Nomograms Univariate Time-related Grouping of categorical variables Univariate Non-time-related Analysis for whole interval Univariate Non-time-related Analysis for predefined intervals Univariate Time-related Analysis (stratified actuarial curves) Univariate Time-related Logit plots Univariate Time-related Transformation of continuous variables Time-related Creation of parametric hazard function (patient (procedure (patient procedural (institutional (patient procedural institutional Multivariable Time-related Patient-specific predictions Multivariable Time-related Generation of nomograms grams ) to discover the shape of relations, the impact of risk factors on one another, and the appearance and disappearance of evident differences, all of which go into drawing helpful clinical inferences, suggesting hypotheses needing basic research, and developing strategies to optimize therapy in the interim. This laborious, costly, time-consuming activity of generating new knowledge contrasts with the present intensive scrutiny of in-hospital outcomes. Governments, societies, institutions, and the media use hospital mortality as an indicator of quality of care in cardiac surgery. The information is based on aggregated data for a surgeon or for a center, and most frequently for all surgical interventions combined, uncorrected for type of intervention, pathology, or comorbidity. It is assumed by many that the operative (30-day) mortality for primary coronary artery bypass grafting (CABG) and for aggregated data should be 2%. Very few authors have actually complete follow-up, even to the 30-day limit; this creates an evident bias in all data without follow-up beyond hospital stay. Figure 3 is the decomposition of the different phases of the hazard of mortality after CABG [2]. The hazard of dying after CABG induced by the preprocedural condition and the procedure stays active for 2 months beyond the data of the procedure. There is no scientific basis to restrict the Fig 3. Decomposition of the three hazard phases (solid lines) composing the overall instantaneous hazard (dotted line) for mortality by any mode at any time after CABG. study of the periprocedural mortality to the hospital stay. Hazard-phase analysis for a particular event identifies the appropriate interval for the study of the periprocedural hazard for that event, for that particular pathology and intervention. The assumption of the 2% risk without extensive correction for pathology and comorbidity is only valid if the risk is similar for every individual patient and close to 2%. The assumption is also valid in the presence of different risks for different patients but with a similar patient mix for every center, surgeon, or institution. This last condition is certainly invalid with the annual changes in patient mix, even within one individual center. A patient-specific prediction uses a generated equation and uses the patient-specific values for every variable in the equation predicting that particular event. Figure 4 presents a patient specific prediction of the 30-day mortality after CABG, calculated for 9600 consecutive patients (K.U. Leuven ) and for the last 1000 Fig 4. Patient-specific prediction of the 30-day mortality after CABG, calculated for 9600 consecutive patients (K.U. Leuven ) and for the last 1000 patients of that same data set, sorted by increasing mortality.
4 Ann Thorac Surg SERGEANT AND BLACKSTONE 1999;68:362 6 CLOSING THE LOOP 365 Fig 5. Patient-specific prediction of the 20-year survival after CABG, calculated for 9600 consecutive patients (K.U. Leuven ), sorted by decreasing survival. Only the lines representing the minimum, the maximum, and the different 1%, 5%, 10%, 25%, 50%, and 75% are defined. patients of that same data set, sorted by increasing mortality. The information presented in this plot is comprehensive. There is a 100-fold spread in 30-day mortality of the 9600 primary CABG patients. This spread was reduced to 50-fold in the last 1000 patients of that particular data set. The hospital mortality for most CABG patients has been extremely low (2400 patients, or 25%, had an operative mortality of less than 0.4%), and most of the mortality is concentrated in few patients with horrendous pathology and comorbidity. Some of these patients combined cardiac arrest at the start of surgery with old age and other comorbidity. Any statement concerning an average 30-day mortality is therefore groundless. Any national or institutional audit or quality control methodology without extensive correction for this variability is a scientifically invalid method. Recently, Osswald and colleagues have confirmed that it is the highest risk patients whose risk is most likely to be underestimated by 30-day mortality [3]. However, hospital information is readily available, relatively inexpensive to gather, particularly if confined to administrative and computerized laboratory data, and thus appealing to institutions and providers who tend to focus on short-term issues rather than the long-term care of patients. Another inference of Figure 4 concerns least invasive techniques of CABG. Aggregated data resulting in a 2% 30-day mortality might seem comparable with standard techniques for the uninformed but are similarly misleading, since the comorbidity of the patients undergoing less-invasive CABG is usually extremely low. The comparable 30-day mortality should be more in the 0.2% to 0.5% range. Randomized trials comparing less-invasive CABG techniques in low-risk patients will therefore have very large sample sizes. Informed consent to a patient is usually based on a medical cost-benefit calculation. The issue of the cost, expressed as the periprocedural mortality, has been addressed already. The benefit, expressed as the longterm survival, is usually based on an intuitive appreciation by the attending physician of the residual survival reserves. Figure 5 represents the wide spectrum of the survival of our CABG population. Similarly as in 30-day mortality, a very good long-term survival is identified in 25% of the patients, a good one in an additional 25%, and an acceptable one in another 25%. The worst survival is accumulated in the last 1% of the population. It should be clear that only patient-specific predictions, based on long-term follow-up studies, can provide the tools for appropriate medical decision making and informed consent. It is also obvious that honesty toward an audited individual or institution requires that audited interval should be as long as possible, thereby auditing the cost simultaneous with the benefit. Individual surgeons might have an increased periprocedural mortality but with a dramatic gain in late survival, more than compensating for the periprocedural risk. Similar models have been created for alternative therapies [4], and in computro predictions allow more precise comparisons between therapies. Intuition, even for the informed clinician, cannot correct for the complex interactions (Figure 6). Patient-specific nomograms will give a much better insight in differences in surgical strategy. The multivariate time-related parametric analysis [5] of the freedom from angina after primary CABG identified the influence of a single arterial graft (under various conditions) in the two active phases and the additional influence of increasing the number of arterial grafts beyond a single one in the early phase ( p ). Similarly, the same analysis detected major influences of younger age in both phases of the hazard. It is impossible for the clinician to understand the size of these influences, and even less how their respective influences interact with one another. Fig 6. Patient-specific nomogram of the 10-year survival after CABG, for a patient with median values for all risk factors (relevant for this event). The median patient is presented with an ejection fraction of 40%, with and without chronic atrial fibrillation and with changing 1-second expiratory volumes (expressed as a percent from normal).
5 366 SERGEANT AND BLACKSTONE Ann Thorac Surg CLOSING THE LOOP 1999;68:362 6 Figure 7 quantifies the benefit, on the freedom from angina after primary CABG, of using a second internal thoracic artery versus only one. It is obvious that the benefit will have very little clinical relevance either at 1 or 5 years and this for the whole spectrum of age at operation. An essential step in closing the loop in evidence-based medical care is the study of the validity of the generated equations on independent study samples. The conditions of this validity have been well identified in a study [6] of previously described equations on an independent population of 3720 patients followed for 5 years. Closing the loop, from treating patients, studying their early and late follow-up, and using that generated knowledge in the treatment of the future patients, is what medicine should be all about. The generated knowledge can cover many domains. Some of these domains are the variability in pathology, in treatment and in patient spectrum. The generated knowledge should help the attending physician in the actual care of an individual patient by solving the differential therapy problem, a more documented informed consent, optimizing therapeutic strategy at primary care, and at return of symptoms. Evidence-based medicine should similarly guide departmental management as well as departmental quality control. Fig 7. Patient-specific nomogram of the 1-year and 5-year difference in freedom from angina after primary CABG, for a patient with median values for all risk factors (relevant for this event). The median patient is a triple-vessel disease patient presented with changing age at operation. References 1. Blackstone E, Naftel D, Turner M. The decomposition of time-varying hazards into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc 1986;81: Sergeant P, Blackstone E, Meyns B, K.U. Leuven Coronary Surgery Program. Validation and interdependence with patient-variables of the influence of procedural variables on early and late survival after CABG. Eur J Cardiothorac Surg 1997;12: Osswald BR, Blackstone EH, Tochtermann U, Thomas G, Vahl CF, Hagl S. The meaning of early mortality after CABG. Eur J Cardiothorac Surg 1999;15: Kirklin J, Barratt-Boyes B. Patient-specific predictions and comparisons in ischemic heart disease. In: Kirklin J, Barratt- Boyes B, eds. Cardiac surgery II. New York: Churchill Livingstone, 1991: Sergeant P, Blackstone E, Meyns B. Is return of angina after coronary artery bypass grafting immutable, can it be delayed, and is it important? J Thorac Cardiovasc Surg 1998;116: Sergeant P, Blackstone E, Meyns B. Can the outcome of coronary bypass grafting be predicted reliably? Eur J Cardiothorac Surg 1997;11:2 9.
Coronary artery bypass grafting (CABG) is a temporary treatment for a
Surgery for Acquired Cardiovascular Disease Influence of patient characteristics and arterial grafts on freedom from coronary reoperation Joseph F. Sabik III, MD, a Eugene H. Blackstone, MD, a,b A. Marc
More informationRisk Stratification Using The Society of Thoracic Surgeons Program
Risk Stratification Using The Society of Thoracic Surgeons Program Brack G. Hattler, MD, PhD, Carol Madia, PA, Carol Johnson, CRNP, John M. Armitage, MD, Robert L. Hardesty, MD, Robert L. Kormos, MD, Si
More informationAnalysis of Mortality Within the First Six Months After Coronary Reoperation
Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic
More informationCoronary artery bypass grafting has evolved into
J. MAXWELL CHAMBERLAIN MEMORIAL PAPER Does Arterial Revascularization Decrease the Risk of Infarction After Coronary Artery Bypass Grafting? Paul T. Sergeant, MD, PhD, Eugene H. Blackstone, MD, and Bart
More informationCoronary atherosclerotic heart disease remains the number
Twenty-Year Survival After Coronary Artery Surgery An Institutional Perspective From Emory University William S. Weintraub, MD; Stephen D. Clements, Jr, MD; L. Van-Thomas Crisco, MD; Robert A. Guyton,
More informationDoes preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting?
Ad et al Acquired Cardiovascular Disease Does preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting? Niv Ad, MD, a Scott D. Barnett, PhD,
More information2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome
Measure #445 (NQF 0119): Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG) National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More information16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900
CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in ESRD patients, with atherosclerotic heart disease and congestive heart
More informationAccepted Manuscript. Simulating the trajectory of off-pump surgery- the heroic defense of the homograft. Ari A. Mennander, MD PhD
Accepted Manuscript Simulating the trajectory of off-pump surgery- the heroic defense of the homograft Ari A. Mennander, MD PhD PII: S0022-5223(18)31728-8 DOI: 10.1016/j.jtcvs.2018.05.112 Reference: YMTC
More informationThe article by Stamou and colleagues [1] found that
THE STATISTICIAN S PAGE Propensity Score Analysis of Stroke After Off-Pump Coronary Artery Bypass Grafting Gary L. Grunkemeier, PhD, Nicola Payne, MPhiL, Ruyun Jin, MD, and John R. Handy, Jr, MD Providence
More informationROBOTIC CARDIAC SURGERY
ROBOTIC CARDIAC SURGERY N. Bonaros Department of Cardiac Surgery Innsbruck Medical University NEGATIVE PROPHECIES GOOD OMENS N Bonaros ESCVS Regensburg 2013 ROBOTIC CORONARY ARTERY BYPASS HAS SURVIVED
More informationDESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft
Measure #43 (NQF 0134): Coronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Patients with Isolated CABG Surgery National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationSetting The setting was a hospital. The economic study was carried out in Australia.
Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,
More informationESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH
ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO
More informationJournal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL
More information2/28/2010. The 3rd Asian Heart & Vascular Symposium. The 3rd Asian Heart & Vascular Symposium. Quality indicator
The 3rd Asian Heart & Vascular Symposium The 3rd Asian Heart & Vascular Symposium A Quality Study of CABG Surgery in Asian Americans in California What have we learnt? Diana Lau, RN, PhD, CNS Administrative
More informationImpaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events
Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts
More informationMeasure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care
Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationUnit 1 Exploring and Understanding Data
Unit 1 Exploring and Understanding Data Area Principle Bar Chart Boxplot Conditional Distribution Dotplot Empirical Rule Five Number Summary Frequency Distribution Frequency Polygon Histogram Interquartile
More informationCardiac disease is well known to be the leading cause
Coronary Artery Bypass Grafting in Who Require Long-Term Dialysis Leena Khaitan, MD, Francis P. Sutter, DO, and Scott M. Goldman, MD Main Line Cardiothoracic Surgeons, Lankenau Hospital, Jefferson Health
More informationEuroSCORE Predicts Short- and Mid-Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients
c 2009 Wiley Periodicals, Inc. 637 EuroSCORE Predicts Short- and Mid-Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients Kimiyoshi J. Kobayashi, B.S., Jason A. Williams,
More informationChanging profile of patients undergoing redo-coronary artery surgery q
European Journal of Cardio-thoracic Surgery 21 (2002) 205 211 www.elsevier.com/locate/ejcts Changing profile of patients undergoing redo-coronary artery surgery q Frans M. van Eck, Luc Noyez*, Freek W.A.
More informationCLINICAL COMMUNIQUE 16 YEAR RESULTS
CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced
More informationFEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,
More informationAtrial fibrillation (AF) is associated with increased morbidity
Ablation of Atrial Fibrillation with Concomitant Surgery Edward G. Soltesz, MD, MPH, and A. Marc Gillinov, MD Atrial fibrillation (AF) is associated with increased morbidity and mortality in coronary artery
More informationContemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology
Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationEvaluation of cardiac surgery mortality rates: 30-day mortality or longer follow-up?
European Journal of Cardio-Thoracic Surgery 44 (2013) 875 883 doi:10.1093/ejcts/ezt119 Advance Access publication 7 March 2013 ORIGINAL ARTICLE a b c d e f Evaluation of cardiac surgery mortality rates:
More informationSupplementary Online Content
1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing
More informationSURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS?
SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS? Luigi Martinelli Chief, Dept. of Surgery Istituto Clinico Ligure di Alta Specialità RAPALLO During 1987 2006,
More informationChapter 4: Cardiovascular Disease in Patients With CKD
Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for
More informationDesign and Simulation of Blocked Blood Vessel for Early Detection of Heart Diseases
Proceedings of the 215 2nd International Symposium on Physics and Technology of Sensors, 8-1th March, 215, Pune, India Design and Simulation of Blocked Blood Vessel for Early Detection of Heart Diseases
More informationThe use of mitral valve (MV) repair to correct mitral
Outcomes and Long-Term Survival for Patients Undergoing Repair Versus Effect of Age and Concomitant Coronary Artery Bypass Grafting Vinod H. Thourani, MD; William S. Weintraub, MD; Robert A. Guyton, MD;
More informationWhen should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER
When should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER ICPS, Massy ICV-GVM La Roseraie, Aubervilliers Hôpital FOCH, Suresnes Disclosure Statement of Financial
More informationChapter 9: Cardiovascular Disease in Patients With ESRD
Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in adult ESRD patients, with atherosclerotic heart disease and congestive heart failure being the most common conditions
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationORIGINAL ARTICLE. Introduction
ORIGINAL ARTICLE Vasc Fail 2018; 2: 25-31 A Cost-benefit Analysis of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting using Reimbursement Data of Japan: A Single-center Pilot Study
More informationThe Journal of Thoracic and Cardiovascular Surgery
Accepted Manuscript Nitric Oxide: Might make it Better? J. Hunter Mehaffey, MD, MSc, Robert B. Hawkins, MD, MSc PII: S0022-5223(18)32342-0 DOI: 10.1016/j.jtcvs.2018.08.070 Reference: YMTC 13398 To appear
More informationPreoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?
Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed
More informationAppropriate Patient Selection or Healthcare Rationing? Lessons from Surgical Aortic Valve Replacement in The PARTNER I Trial Wilson Y.
Appropriate Patient Selection or Healthcare Rationing? Lessons from Surgical Aortic Valve Replacement in The PARTNER I Trial Wilson Y. Szeto, MD on behalf of The PARTNER Trial Investigators and The PARTNER
More informationSurgical Ablation for Lone AF: What have we learned after 30 years?
Surgical Ablation for Lone AF: What have we learned after 30 years? Ralph J. Damiano, Jr., MD Evarts A. Graham Professor of Surgery Chief of Cardiothoracic Surgery Vice Chairman, Department of Surgery
More informationSYNTAX III REVOLUTION Trial Press briefing conference. Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London
SYNTAX III REVOLUTION Trial Press briefing conference Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London Title: Coronary Computed Tomography Angiography for Heart Team Decision-making
More informationMitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation
Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Matthew L. Williams, MD, Mani A. Daneshmand, MD, James G. Jollis, MD, John
More informationMeasure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care
Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:
More informationBelow is summarised some of the tools and papers that are worth looking at if you have an interest in the area.
What happens to the high risk patients who don t die? Perioperative SIG meeting PBLD Noosa 2015 Nicola Broadbent, Auckland, NZ In the process of writing this problem based learning discussion I have read
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationSix Sigma Glossary Lean 6 Society
Six Sigma Glossary Lean 6 Society ABSCISSA ACCEPTANCE REGION ALPHA RISK ALTERNATIVE HYPOTHESIS ASSIGNABLE CAUSE ASSIGNABLE VARIATIONS The horizontal axis of a graph The region of values for which the null
More informationMandatory knowledge about natural history of coronary grafts. P.Sergeant P. Maureira K.U.Leuven, Belgium
Mandatory knowledge about natural history of coronary grafts P.Sergeant P. Maureira K.U.Leuven, Belgium Types of grafts Arterial ITA/IMA (internal thoracic/mammary artery) Radial artery Gastro-epiploïc
More informationVASCULAR DISEASE MANAGEMENT SURVEY FROM THE ESC COUNCIL FOR CARDIOLOGY PRACTICE AND THE ESC WORKING GROUP ON AORTA AND PERIPHERAL VASCULAR DISEASES
VASCULAR DISEASE MANAGEMENT SURVEY FROM THE ESC COUNCIL FOR CARDIOLOGY PRACTICE AND THE ESC WORKING GROUP ON AORTA AND PERIPHERAL VASCULAR DISEASES RICCARDO ASTEGGIANO MD, FESC VICTOR ABOYANS MD, PhD,
More informationTAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con
TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con Dimitrios C. Angouras, MD, FETCS Associate Professor of Cardiac Surgery National and Kapodistrian University of Athens,
More informationIS RESECTION OF PULMONARY AND HEPATIC METASTASES WARRANTED IN PATIENTS WITH COLORECTAL CANCER?
IS RESECTION OF PULMONARY AND HEPATIC METASTASES WARRANTED IN PATIENTS WITH COLORECTAL CANCER? Brigitta J. Robinson, MD a Thomas W. Rice, MD a Scott A. Strong, MD b Lisa A. Rybicki, MS c Eugene H. Blackstone,
More informationDeclaration of conflict of interest NONE
Declaration of conflict of interest NONE Claudio Muneretto MD, PhD Director of Division of Cardiac Surgery University of Brescia Medical School Italy Hybrid Chymera Different features and potential advantages
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationComplex Thoracoscopic Resections for Locally Advanced Lung Cancer
Complex Thoracoscopic Resections for Locally Advanced Lung Cancer Duke Thoracoscopic Lobectomy Workshop March 21, 2018 Thomas A. D Amico MD Gary Hock Professor of Surgery Section Chief, Thoracic Surgery,
More informationReview guidance for patients on long-term amiodarone treatment
Review guidance for patients on long-term amiodarone treatment This review guidance document has been produced in response to: 1. Current supply shortages of branded and generic versions of 100mg and 200mg
More informationPredictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
Pediatr Transplantation 2013: 17: 436 440 2013 John Wiley & Sons A/S. Pediatric Transplantation DOI: 10.1111/petr.12095 Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
More informationIn the United States, 97 million overweight or obese
The Risks of Moderate and Extreme Obesity for Coronary Artery Bypass Grafting Outcomes: A Study From The Society of Thoracic Surgeons Database Ganga Prabhakar, MD, Constance K. Haan, MD, Eric D. Peterson,
More informationCoronary Artery Bypass Graft: Monitoring Patients and Detecting Complications
Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University
More informationDoes the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation?
Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Cliff K. Choong, FRACS, Bryan F. Meyers, MD, Tracey J. Guthrie, BSN, Elbert P. Trulock,
More informationAssessing Agreement Between Methods Of Clinical Measurement
University of York Department of Health Sciences Measuring Health and Disease Assessing Agreement Between Methods Of Clinical Measurement Based on Bland JM, Altman DG. (1986). Statistical methods for assessing
More informationQuality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care
Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationCost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J
Cost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J Record Status This is a critical abstract of an economic evaluation that meets the
More informationSurgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018
Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report May 2018 Prepared by the Canadian Cardiovascular Society (CCS)/Canadian Society of Cardiac Surgeons (CSCS) Cardiac
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationProtocol Development: The Guiding Light of Any Clinical Study
Protocol Development: The Guiding Light of Any Clinical Study Susan G. Fisher, Ph.D. Chair, Department of Clinical Sciences 1 Introduction Importance/ relevance/ gaps in knowledge Specific purpose of the
More informationTAVI SURVEY. Performed by the ESC Council for Cardiology Practice
TAVI SURVEY Performed by the ESC Council for Cardiology Practice BACKGROUND To evaluate the knowledge and the behaviour of a large community of cardiologists working in different settings, both in hospital
More informationBiostatistics for Med Students. Lecture 1
Biostatistics for Med Students Lecture 1 John J. Chen, Ph.D. Professor & Director of Biostatistics Core UH JABSOM JABSOM MD7 February 14, 2018 Lecture note: http://biostat.jabsom.hawaii.edu/education/training.html
More informationManagement Strategy for Simultaneous Carotid Endarterectomy and Coronary Revascularization
Management Strategy for Simultaneous Carotid Endarterectomy and Coronary Revascularization Gregory D. Trachiotis, MD, and Albert J. Pfister, MD Washington Heart, Section for Thoracic and Cardiovascular
More informationRisk Score for Predicting In-Hospital/30-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery
Risk Score for Predicting In-Hospital/3-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery Edward L. Hannan, PhD, Michael Racz, PhD, Alfred T. Culliford, MD, Stephen
More informationNon-Selective Carotid Artery Ultrasound Screening in Patients Undergoing Coronary Artery Bypass Grafting: Is It Necessary?
Non-Selective Carotid Artery Ultrasound Screening in Patients Undergoing Coronary Artery Bypass Grafting: Is It Necessary? Khalil Masabni, Joseph F. Sabik III, Sajjad Raza, Theresa Carnes, Hemantha Koduri,
More informationThe effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries. Dr. Christian Finley MD MPH FRCSC McMaster University
The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries Dr. Christian Finley MD MPH FRCSC McMaster University Disclosures I have no conflict of interest disclosures
More informationLecture Outline. Biost 590: Statistical Consulting. Stages of Scientific Studies. Scientific Method
Biost 590: Statistical Consulting Statistical Classification of Scientific Studies; Approach to Consulting Lecture Outline Statistical Classification of Scientific Studies Statistical Tasks Approach to
More informationQuality ID #166 (NQF 0131): Coronary Artery Bypass Graft (CABG): Stroke- National Quality Strategy Domain: Effective Clinical Care
Quality ID #166 (NQF 0131): Coronary Artery Bypass Graft (CABG): Stroke- National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Outcome
More informationOn-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery
On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict
More informationReoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment
Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background
More informationThe European System for Cardiac Operative Risk. Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery
Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery Fausto Biancari, MD, PhD, Francesco Vasques, MS, Reija Mikkola, MS, Marta Martin, MS, Jarmo Lahtinen, MD, PhD, and Jouni
More informationSPRING GROVE AREA SCHOOL DISTRICT. Course Description. Instructional Strategies, Learning Practices, Activities, and Experiences.
SPRING GROVE AREA SCHOOL DISTRICT PLANNED COURSE OVERVIEW Course Title: Basic Introductory Statistics Grade Level(s): 11-12 Units of Credit: 1 Classification: Elective Length of Course: 30 cycles Periods
More informationBiostatistics II
Biostatistics II 514-5509 Course Description: Modern multivariable statistical analysis based on the concept of generalized linear models. Includes linear, logistic, and Poisson regression, survival analysis,
More informationAccepted Manuscript. Radial artery and bilateral mammary arteries in CABG: how much is too much? Derrick Y. Tam, MD, Stephen E.
Accepted Manuscript Radial artery and bilateral mammary arteries in CABG: how much is too much? Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc PII: S0022-5223(19)30032-7 DOI: https://doi.org/10.1016/j.jtcvs.2019.01.009
More informationIndication, Timing, Assessment and Update on TAVI
Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationinvestigate. educate. inform.
investigate. educate. inform. Research Design What drives your research design? The battle between Qualitative and Quantitative is over Think before you leap What SHOULD drive your research design. Advanced
More informationThe Journal of Thoracic and Cardiovascular Surgery
Accepted Manuscript Judgement Day: Should You Add Atrial Fibrillation Ablation? Dr. Patrick M. McCarthy, MD PII: S0022-5223(18)32917-9 DOI: https://doi.org/10.1016/j.jtcvs.2018.11.004 Reference: YMTC 13719
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #44 (NQF 0236): Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR
More informationCoronary artery bypass grafting (CABG) is one of the most intensely scrutinized
Surgery for Acquired Cardiovascular Disease Novick et al Direct comparison of risk-adjusted and non risk-adjusted CUSUM analyses of coronary artery bypass surgery outcomes Richard J. Novick, MD, a Stephanie
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative
More informationChapter 8: Cardiovascular Disease in Patients with ESRD
Chapter 8: Cardiovascular Disease in Patients with ESRD Cardiovascular disease (CVD) is common in adult end-stage renal disease (ESRD) patients, with coronary artery disease (CAD) and heart failure (HF)
More informationLong-term relative survival after primary heart valve replacement 1
European Journal of Cardio-thoracic Surgery 11 (1997) 81 91 Long-term relative survival after primary heart valve replacement 1 Abstract E. Ståhle a, *, P. Kvidal b, S.O. Nyström a, R. Bergström c a Department
More informationPresenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose
Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material
More informationOccurrence of Bleeding and Thrombosis during Antiplatelet therapy In Non-cardiac surgery. A prospective observational study.
Occurrence of Bleeding and Thrombosis during Antiplatelet therapy In Non-cardiac surgery A prospective observational study OBTAIN Study Statistical Analysis Plan of Final Analysis Final Version: V1.1 from
More informationRecording and Evaluation of Co-Morbidity - An Update. Jill Birch University of Manchester
Recording and Evaluation of Co-Morbidity - An Update Jill Birch University of Manchester Introduction Co-morbidity included in Adult cancer datasets from outset Measures to be used uncertain Uncertainty
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of
More informationAtrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database
Atrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database James S. Gammie, MD, Michel Haddad, MD, Sarah Milford-Beland, MS, Karl F. Welke, MD, T. Bruce
More informationEstablishing a New Path Forward for Patients With Severe Symptomatic Aortic Stenosis THE PARTNER TRIAL CLINICAL RESULTS
Establishing a New Path Forward for Patients With Severe Symptomatic Aortic Stenosis THE PARTNER TRIAL CLINICAL RESULTS E D W A R D S T R A N S C A T H E T E R H E A R T V A L V E P R O G R A M T h e Pa
More informationPostoperative atrial fibrillation is not an innocuous arrhytmia in LAVD patients
Accepted Manuscript Postoperative atrial fibrillation is not an innocuous arrhytmia in LAVD patients Cipriano Abad, MD, PhD, FEBS(Hon, Gen Surg), EBCTS, Stefano Urso, MD, PhD, Bernardino Clavo, MD, PhD
More informationStatistical analysis DIANA SAPLACAN 2017 * SLIDES ADAPTED BASED ON LECTURE NOTES BY ALMA LEORA CULEN
Statistical analysis DIANA SAPLACAN 2017 * SLIDES ADAPTED BASED ON LECTURE NOTES BY ALMA LEORA CULEN Vs. 2 Background 3 There are different types of research methods to study behaviour: Descriptive: observations,
More informationIschemic Versus Degenerative Mitral Regurgitation: Does Etiology Affect Survival?
Ischemic Versus Degenerative Mitral Regurgitation: Does Etiology Affect Survival? A. Marc Gillinov, MD, Eugene H. Blackstone, MD, Jeevanantham Rajeswaran, MS, Maurice Mawad, MD, Patrick M. McCarthy, MD,
More information